EPIX
ESSA Pharma
EPIX
EPIX
Delisted
EPIX was delisted on the 8th of October, 2025.
36 hedge funds and large institutions have $52.7M invested in ESSA Pharma in 2025 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 9 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
1.6% less ownership
Funds ownership: 71.37% → 69.77% (-1.6%)
22% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 9
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
36
Holding in Top 10
2
Calls
$1.57M
Puts
$597K
Top Buyers
| 1 | +$340K | |
| 2 | +$289K | |
| 3 | +$223K | |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$107K |
| 5 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
+$85K |
Top Sellers
| 1 | -$174K | |
| 2 | -$153K | |
| 3 | -$120K | |
| 4 |
Two Sigma Investments
New York
|
-$96.5K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$47.7K |
